Vimarsana
Biggest News Aggregation in the World

Page 38 - Ischemic Stroke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ischemic Stroke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ischemic Stroke Today - Breaking & Trending Today

Thrombectomy Benefits Stroke With Large Core Volumes: SELECT2 - Vimarsana News

Thrombectomy Benefits Stroke With Large Core Volumes: SELECT2

A new international trial has shown large benefits of thrombectomy in patients with ischemic strokes with a large core volume, which should lead to a change in clinical practice.

New Smartphone App Tracks Stroke Signs - Vimarsana News

New Smartphone App Tracks Stroke Signs

How to spot the signs of stroke? A new smartphone application called FAST.AI may recognize common stroke symptoms as they are happening.

Lifestyle-related metabolite biomarker may be a target to reduce stroke risk in Black adults - Vimarsana News

Lifestyle-related metabolite biomarker may be a target to reduce stroke risk in Black adults

Researchers have identified a lifestyle-related metabolite biomarker called gluconic acid that is associated with high blood pressure, increased risk of ischemic stroke, eating a Southern diet, lower level of education and lack of exercise, among Black adults, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2023.

Common oral bacteria tied to brain microbleeds, stroke risk - Vimarsana News

Common oral bacteria tied to brain microbleeds, stroke risk

Higher numbers of cerebral microbleeds were found in stroke patients who had Cnm-postive Streptococcus mutans in the mouth, according to a study.

The safety profile of the first and second monovalent and bivalent BNT162b2 mRNA booster vaccines in older adults - Vimarsana News

The safety profile of the first and second monovalent and bivalent BNT162b2 mRNA booster vaccines in older adults

Researchers evaluated the safety profiles of booster doses of the monovalent and bivalent mRNA COVID-19 vaccine BNT162b2 in adults above the age of 60.